KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) Enterprise Value (2020 - 2026)

Organon has reported Enterprise Value over the past 7 years, most recently at -$1.1 billion for Q1 2026.

  • For Q1 2026, Enterprise Value fell 104.02% year-over-year to -$1.1 billion; the TTM value through Mar 2026 reached -$1.1 billion, down 104.02%, while the annual FY2025 figure was -$574.0 million, 18.47% up from the prior year.
  • Enterprise Value for Q1 2026 was -$1.1 billion at Organon, down from -$574.0 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$326.0 million in Q2 2023 and troughed at -$1.1 billion in Q1 2026.
  • A 5-year average of -$623.5 million and a median of -$599.0 million in 2025 define the central range for Enterprise Value.
  • On a YoY basis, Enterprise Value climbed as much as 50.5% in 2022 and fell as far as 392.2% in 2022.
  • Year by year, Enterprise Value stood at -$706.0 million in 2022, then increased by 0.57% to -$702.0 million in 2023, then fell by 0.28% to -$704.0 million in 2024, then rose by 18.47% to -$574.0 million in 2025, then plummeted by 94.43% to -$1.1 billion in 2026.
  • Business Quant data shows Enterprise Value for OGN at -$1.1 billion in Q1 2026, -$574.0 million in Q4 2025, and -$672.0 million in Q3 2025.